Question 1

What are typical ER visit rate benchmarks for employer health plans?

Accepted Answer

For 2025, median ER visit rates for employer-sponsored plans are 150–200 visits per 1,000 covered members per year. Rates above 250 per 1,000 indicate potential overutilization and opportunities for telemedicine, urgent care redirection, and care navigation. ER visits average $1,500–$3,000 per visit (facility fee only), making ER reduction one of the highest-ROI utilization management strategies. Telemedicine programs typically reduce ER visits by 10–20% for conditions that can be treated virtually.

Question 2

What are typical specialist visit rate benchmarks?

Accepted Answer

Median specialist visit rates for employer-sponsored plans are 2.5–3.5 specialist visits per member per year. Rates significantly above benchmark may indicate lack of primary care access (driving direct specialist utilization), poor care coordination, or high chronic disease burden. Direct primary care (DPC) programs typically reduce specialist referrals by 15–25% by enabling primary care physicians to manage more conditions in-house. Navigation programs reduce unnecessary specialist visits by helping members understand when specialist care is truly needed.

Question 3

What chronic condition prevalence benchmarks should employers track?

Accepted Answer

Key chronic condition prevalence benchmarks for employer populations: diabetes — 8–12% of covered members; hypertension — 20–25%; obesity (BMI 30+) — 35–40%; depression/anxiety — 15–20%; musculoskeletal conditions — 25–30%. Prevalence significantly above benchmark suggests opportunities for targeted disease management programs. Use your TPA's claims data to calculate your plan's chronic condition prevalence and compare against these benchmarks.

Question 4

What is a good generic dispensing rate benchmark for pharmacy utilization?

Accepted Answer

The generic dispensing rate (GDR) — the percentage of prescriptions filled with generic drugs — is a key pharmacy utilization benchmark. For 2025, median GDR for employer-sponsored plans is 85–90%. Plans with GDR below 80% have significant generic substitution opportunities. Generic drugs cost 80–90% less than brand-name equivalents for the same therapeutic effect. PBMs can improve GDR through formulary design, step therapy, and member education programs.

Question 5

How do I use utilization data to identify cost-containment opportunities?

Accepted Answer

Analyze utilization data across five dimensions: (1) ER utilization — identify members with 3+ ER visits per year for care management outreach; (2) Specialty drug utilization — identify high-cost specialty drug users for clinical management; (3) Chronic condition management — identify members with uncontrolled chronic conditions for disease management; (4) Site-of-care — identify procedures performed in high-cost settings that could be redirected; (5) Preventive care gaps — identify members not receiving recommended preventive services. Your TPA should provide monthly utilization reports with these dimensions.

Healthcare Utilization Benchmarks

Key benchmark figures

Data sources

Health Care Cost and Utilization Report

Health Analytics Report

Employer Health Benefits Survey

National Survey of Employer-Sponsored Health Plans

Health Plan Effectiveness Report

Large Employers Health Care Strategy Survey

Related tools & resources